Morphogens and growth factor signalling in the myeloma bone-lining niche
Multiple myeloma is a malignancy caused by the clonal expansion of abnormal plasma cells. Myeloma cells have proven to be incredibly successful at manipulating their microenvironment to promote growth and to evade modern therapies. They have evolved to utilise the integral signalling pathways of the...
主要な著者: | Morris, EV, Edwards, CM |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Springer
2021
|
類似資料
-
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
著者:: Gooding, S, 等
出版事項: (2019) -
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
著者:: Sarah Gooding, 等
出版事項: (2019-10-01) -
PB2082: BONE MORPHOGENIC PROTEIN-6 PROMOTES THE PROLIFERATION AND INHIBITS APOPTOSIS IN MULTIPLE MYELOMA
著者:: Jiaqi Fu, 等
出版事項: (2023-08-01) -
Myeloma and marrow adiposity: Unanswered questions and future directions
著者:: Morris, EV, 等
出版事項: (2021) -
The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
著者:: Gámez, B, 等
出版事項: (2021)